financetom
Business
financetom
/
Business
/
Euro Manganese in Offtake Agreement With Wildcat Discovery Technologies
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Euro Manganese in Offtake Agreement With Wildcat Discovery Technologies
Aug 19, 2024 7:12 AM

09:47 AM EDT, 08/19/2024 (MT Newswires) -- Euro Manganese ( EMNAF ) on Monday said it inked an offtake agreement with Wildcat Discovery Technologies for the sale of high-purity manganese product from Euro's Chvaletice Manganese Project in the Czech Republic.

San Diego-based Wildcat partners with companies in the battery industry to help them achieve optimal performance, and is exclusively focused on nickel and cobalt free cathode production. Wildcat has announced the building of a U.S. plant in 2026-2027 to produce a portfolio of cobalt/nickel-free cathode materials for electric vehicle battery cells and other markets including stationary storage.

The term of the accord is for an initial seven years with potential for renewal and pricing is expected to be subject to market indicators. Deliveries will be subject to Euro Manganese ( EMNAF )' Chvaletice Demonstration Plant meeting Wildcat specifications.

While the term sheet is non-binding and contingent on Wildcat building its U.S. plant, both parties intend to enter a binding offtake agreement.

"This long-term offtake term sheet represents a significant percentage of the planned production of the Chvaletice Manganese Project over time," said Euro CEO Matthew James. "An important value proposition is our product does not originate from, or is processed by, a foreign entity of concern, a key purchasing criteria for North American customers."

Last week, Euro Manganese ( EMNAF ) hit a 52-week low of $0.035 on the TSX Venture Exchange before rebounding 14% on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AppLovin Insider Sold Shares Worth $8,238,139, According to a Recent SEC Filing
AppLovin Insider Sold Shares Worth $8,238,139, According to a Recent SEC Filing
Nov 25, 2025
03:52 AM EST, 11/25/2025 (MT Newswires) -- Arash Adam Foroughi, 10% Owner, Director, Chief Executive Officer & Chairperson, on November 21, 2025, sold 15,931 shares in AppLovin ( APP ) for $8,238,139. Following the Form 4 filing with the SEC, Foroughi has control over a total of 5,294,055 Class A common shares of the company, with 5,294,055 controlled indirectly. SEC...
Thermo Fisher Scientific Prices Offering of Euro-Denominated Notes at 100% of Par Value
Thermo Fisher Scientific Prices Offering of Euro-Denominated Notes at 100% of Par Value
Nov 25, 2025
03:57 AM EST, 11/25/2025 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) said late Monday it priced an offering of 2.1 billion euros ($2.42 billion) of senior notes at 100% of par value. The offering consists of 1 billion euros of floating rate senior notes due 2027 and 1.1 billion euros of 3.628% senior notes due 2035. Net proceeds...
Roblox Insider Sold Shares Worth $2,005,239, According to a Recent SEC Filing
Roblox Insider Sold Shares Worth $2,005,239, According to a Recent SEC Filing
Nov 25, 2025
03:30 AM EST, 11/25/2025 (MT Newswires) -- Matthew D Kaufman, Chief Safety Officer, on November 20, 2025, sold 20,867 shares in Roblox ( RBLX ) for $2,005,239. Following the Form 4 filing with the SEC, Kaufman has control over a total of 239,775 Class A common shares of the company, with 239,775 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1315098/000131509825000345/xslF345X05/wk-form4_1764034383.xml ...
Merit Medical Systems Insider Sold Shares Worth $2,182,750, According to a Recent SEC Filing
Merit Medical Systems Insider Sold Shares Worth $2,182,750, According to a Recent SEC Filing
Nov 25, 2025
03:54 AM EST, 11/25/2025 (MT Newswires) -- Fred P. Lampropoulos, Director, Executive Chairman, on November 21, 2025, sold 25,000 shares in Merit Medical Systems ( MMSI ) for $2,182,750. Following the Form 4 filing with the SEC, Lampropoulos has control over a total of 1,136,457 common shares of the company, with 1,029,955 shares held directly and 106,502 controlled indirectly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved